Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy

PURPOSE: We investigated the clinical efficacy of immune checkpoint blocker (ICB) therapy for metastatic or advanced melanoma in Korean patients. As well, we assessed whether the effects of ICBs can be enhanced by combination therapy with palliative radiotherapy (RT). MATERIALS AND METHODS: We retro...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Res Treat
Päätekijät: Lee, Jeongshim, Chang, Jee Suk, Roh, Mi Ryung, Jung, Minkyu, Lee, Choong-Kun, Oh, Byung Ho, Chung, Kee Yang, Koom, Woong Sub, Shin, Sang Joon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Cancer Association 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373866/
https://ncbi.nlm.nih.gov/pubmed/32054150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.598
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia